A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids
- Status
- TERMINATED
- Phase
- NA
Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Young, Empowered & Strong (YES): The Young Women's Breast Cancer Study 2- Focus on Intervention Pilot
- Status
- COMPLETED
- Phase
- NA
A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain
- Status
- COMPLETED
- Phase
- N/A
A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Personal Web Page In Clinical Trial Participant Education
- Status
- COMPLETED
- Phase
- NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- NA
Individualizing Surveillance Mammography for Older Breast Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
EHR-embedded OCDT in Breast or GI Cancer
- Status
- COMPLETED
- Phase
- NA
'ADVANCE' (A Pilot Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Symptom Management Implementation of Patient Reported Outcomes in Oncology
- Status
- COMPLETED
- Phase
- NA
Tucatinib + Abemaciclib + Herceptin for HER2+ MBC
- Status
- WITHDRAWN
- Phase
- PHASE1
A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance
- Status
- COMPLETED
- Phase
- N/A